NCT05817604Active, not recruiting
Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial)
Source: ClinicalTrials.gov · Last updated 10 May 2024
Brief summary (registry, in English)
Study evaluating the activity and efficacy of Stereotactic Body Radiotherapy for the treatment of medically inoperable localized renal cancer
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 5 Apr 2023
- Start date
- 1 Mar 2023
- Primary completion date
- 1 May 2026
- Lead sponsor
- Consorci Sanitari de Terrassa
- Diseases
- Kidney cancer
- NCT number
- NCT05817604
What you commit to
- Study type: Observational
- Planned participants: 60
- From 1 Mar 2023 to the primary completion date, 1 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Non-oncological renal disease or autoinmunological disorder that does not recommend the treatment with radiotherapy.
- Previous local/regional RT
- Concomitance with other antineoplastic drugs
Other
- Life expectancy \<6 months
Who the study is looking for
- Histological diagnosis of Renal tumor and/or highly suspected malignant neoplasm by CT, MRI or PET.
- Tumor Diameter \>1cm - \<7cm
- Tumor visible on CT planning
- Medically inoperable disease (or rejection of surgery)
- Karnofsky Index \>70%
- \>18 y.o.
- Informed Consent signature
Age in the registry: 18 years to 100 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Consorci Sanitari de Terrassa Coordinator of this site? Confirm its status | Terrassa | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.